by Kassandra Frederique, Executive Director of the Drug Policy Alliance “Over the past year, we have witnessed visceral examples of how the systems that purport to protect and support us too often cause harm, especially to communities of color. Yet not enough attention has been given to the central role played by the war […]
Dating violence is a serious issue on many college campuses throughout the country. Unfortunately, substance misuse can make a troubled relationship even more volatile. A study that surveyed 72 female college students, titled “Daily and situational reports of substance use and dating violence among college students: A 10-week prospective study,” took a closer look at this […]
NIH-supported pilot study found team-based approach may improve buprenorphine care. A collaborative approach to treating opioid use disorder that relies heavily on community pharmacists is feasible and may increase adherence and participant satisfaction, according to a pilot study published in Addiction. Most people with opioid use disorder who would benefit from medication do not receive it. […]
The Providence/Boston Center for AIDS Research Substance Use Research Core (CFAR SURC) is the only CFAR Core in the nation that focuses specifically on the intersection of substance use and HIV. The SURC is composed of 16 faculty members, who are leaders in the field of substance use and HIV research, and is led by co-Directors Christopher […]
Sara Becker, PhD, Associate Professor of Behavioral and Social Sciences and of Psychiatry and Human Behavior, has won the 2020 G. Alan Marlatt Mid-Career Research Award from the Addictive Behaviors group of the Association for Behavioral and Cognitive Therapies. Dr. Becker was a COBRE Research Project Leader studying contingency management as a way to improve patient […]
By Mary A. Burke and Riley Sullivan “Since the early 2000s Rhode Island has been among the states hardest hit by the opioid crisis. In response, the state has made it a priority to expand access to medication-assisted treatment (MAT) for opioid use disorder (OUD), which refers to the use of the FDA-approved medications methadone, buprenorphine, and/or naltrexone […]
The government eased access to drug addiction treatment during the pandemic. Now that could go away. When the Covid-19 pandemic forced much of the US to lock down in the spring of 2020, officials and experts worried the necessary social distancing measures would make another public health crisis — the opioid epidemic — worse. Addiction treatment is traditionally done […]
Rhode Island Hospital
1125 N Main Street, Suite 215
Providence, RI 02906
401-793-4783
opioidcobre@lifespan.org
